Amy S Shah1, W Sean Davidson2, Zhiqian Gao3, Lawrence M Dolan4, Thomas R Kimball3, Elaine M Urbina3. 1. Division of Endocrinology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH, USA. Electronic address: amy.shah@cchmc.org. 2. Center for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA. 3. Division of Cardiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH, USA. 4. Division of Endocrinology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH, USA.
Abstract
BACKGROUND: The nuclear magnetic resonance (NMR) lipoprotein profile provides additional cardiovascular risk information beyond traditional lipids in high-risk adults. Similar studies have not been conducted in youth. OBJECTIVE: To evaluate the relationship between the NMR profile and preclinical vascular measures in youth. METHODS: We studied 96 obese youth with prediabetes (mean age = 18.1 ± 3.6 years, 63% female, 78% African American) and 118 obese normoglycemic controls (mean age = 18.0 ± 3.1 years, 75% female, 62% African American) cross sectionally. Traditional lipids (triglycerides, total, high-density lipoprotein [HDL], and low-density lipoprotein [LDL] cholesterol), NMR particle size (particle concentration [P] and size) and vascular thickness (carotid IMT) and stiffness (pulse wave velocity [PWV]) were measured. Independent associations between lipoproteins with carotid IMT and PWV after adjustment for group, age, race, sex, BMI z score, blood pressure, HOMA-IR, and A1c were studied. RESULTS: NMR analysis revealed youth with prediabetes exhibited a more atherogenic profile with higher levels of small LDL-P and HDL-P and lower levels of intermediate and large HDL-P (P < .03). In addition, lower intermediate HDL-P was associated with a higher carotid IMT, whereas higher small HDL-P was associated with a higher PWV (P < .01). Traditional lipids were not significantly different between groups and were not associated with either vascular outcome. CONCLUSIONS: NMR lipoprotein subclasses have improved sensitivity compared to traditional lipids to detect lipoprotein abnormalities in normoglycemic and prediabetic obese youth and are independently associated with preclinical vascular thickness and stiffness. NMR lipids may enhance cardiovascular risk assessment in youth.
BACKGROUND: The nuclear magnetic resonance (NMR) lipoprotein profile provides additional cardiovascular risk information beyond traditional lipids in high-risk adults. Similar studies have not been conducted in youth. OBJECTIVE: To evaluate the relationship between the NMR profile and preclinical vascular measures in youth. METHODS: We studied 96 obese youth with prediabetes (mean age = 18.1 ± 3.6 years, 63% female, 78% African American) and 118 obese normoglycemic controls (mean age = 18.0 ± 3.1 years, 75% female, 62% African American) cross sectionally. Traditional lipids (triglycerides, total, high-density lipoprotein [HDL], and low-density lipoprotein [LDL] cholesterol), NMR particle size (particle concentration [P] and size) and vascular thickness (carotid IMT) and stiffness (pulse wave velocity [PWV]) were measured. Independent associations between lipoproteins with carotid IMT and PWV after adjustment for group, age, race, sex, BMI z score, blood pressure, HOMA-IR, and A1c were studied. RESULTS: NMR analysis revealed youth with prediabetes exhibited a more atherogenic profile with higher levels of small LDL-P and HDL-P and lower levels of intermediate and large HDL-P (P < .03). In addition, lower intermediate HDL-P was associated with a higher carotid IMT, whereas higher small HDL-P was associated with a higher PWV (P < .01). Traditional lipids were not significantly different between groups and were not associated with either vascular outcome. CONCLUSIONS: NMR lipoprotein subclasses have improved sensitivity compared to traditional lipids to detect lipoprotein abnormalities in normoglycemic and prediabetic obese youth and are independently associated with preclinical vascular thickness and stiffness. NMR lipids may enhance cardiovascular risk assessment in youth.
Authors: Elaine M Urbina; Thomas R Kimball; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan Journal: J Hypertens Date: 2010-08 Impact factor: 4.844
Authors: Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora Journal: J Am Coll Cardiol Date: 2012-07-11 Impact factor: 24.094
Authors: Amy S Shah; Zhiqian Gao; Elaine M Urbina; Thomas R Kimball; Lawrence M Dolan Journal: J Clin Endocrinol Metab Date: 2014-01-01 Impact factor: 5.958
Authors: William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino Journal: J Clin Lipidol Date: 2007-12 Impact factor: 4.766
Authors: Alvin Chandra; Ian J Neeland; Sandeep R Das; Amit Khera; Aslan T Turer; Colby R Ayers; Darren K McGuire; Anand Rohatgi Journal: Am J Cardiol Date: 2015-01-15 Impact factor: 2.778
Authors: W Sean Davidson; Anna Heink; Hannah Sexmith; Lawrence M Dolan; Scott M Gordon; James D Otvos; John T Melchior; Deborah A Elder; Jane Khoury; Esmond Geh; Amy S Shah Journal: J Lipid Res Date: 2017-07-25 Impact factor: 5.922
Authors: Flávia De C Cartolano; Gabriela D Dias; Maria C P de Freitas; Antônio M Figueiredo Neto; Nágila R T Damasceno Journal: J Diabetes Res Date: 2017-08-22 Impact factor: 4.011
Authors: Angeliki Makri; Anita Cheung; Ninet Sinaii; Alan T Remaley; Maureen Sampson; Meg Keil; Elena Belyavskaya; Charalampos Lyssikatos; Maria De La Luz Sierra; Constantine A Stratakis; Maya Lodish Journal: Pediatr Res Date: 2019-05-21 Impact factor: 3.756
Authors: Eero A Haapala; Marja H Leppänen; Maarit Lehti; Niina Lintu; Tuomo Tompuri; Anna Viitasalo; Ursula Schwab; Timo A Lakka Journal: Front Endocrinol (Lausanne) Date: 2022-09-23 Impact factor: 6.055
Authors: Hanna Wessel; Ali Saeed; Janette Heegsma; Margery A Connelly; Klaas Nico Faber; Robin P F Dullaart Journal: J Clin Med Date: 2019-10-25 Impact factor: 4.241